Eucalyptus

Executive Summary

Eucalyptus is a leading health technology company in Australia that controls every part of its business. It sells health services directly to patients through its own brands like Pilot, Juniper, and Software. The business is growing fast, doubling its size over the last year to reach a $200 million yearly revenue pace. At the same time, it reduced its yearly loss to $15 million. Eucalyptus uses its own software that lets patients message doctors instead of talking in real-time. This helps them compete with international giants like Hims & Hers and Ro, especially by selling the popular new GLP-1 weight-loss drugs. A successful move into the United Kingdom provides a plan for how the company can grow into even more countries outside of its home market. Eucalyptus stays ahead of its rivals by using its own private technology and a specific group of licensed doctors. These tools help them keep customers for a long time, which makes each user more valuable. However, anyone putting money into the business must consider that government officials in Australia and the United Kingdom are looking more closely at the laws that govern how doctors prescribe medicine online. Eucalyptus is a top Australian technology export and represents a rare chance for the public to buy shares in a company where digital shopping meets medical care.